TO COMPARE 0.125% ROPIVACAINE WITH FENTANYL WITH 0.2 % ROPIVACAINE ONLY IN POSTOPERATIVE PAIN MANAGEMENT THROUGH COMBINED SPINAL EPIDURAL ANAESTHESIA
Phase 4
Completed
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2020/12/029501
- Lead Sponsor
- Department of Anaesthesiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1) Patients of either gender aged between 18 to 65 years.
2) ASA grade 1 and 2
3) patients scheduled for elective lower limb orthopaedic surgeries under combined spinal epidural anaesthesia.
Exclusion Criteria
1) All patients with ASA grade 3 and above,
2) ALL patients with known allergy to study drugs.
3) All known contraindications to spinal anaesthesia and epidural insertions
4) Patients with previous spine abnormalities and spine surgeries.
5)Patients with history of underlying neuromuscular and pyschological disorder
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TO EVALUATE THE POSTOPERATIVE ANALGESIC EFFFICAY OF 0.125% ROPIVACIANE WITH FENTANYL AND TO EVALUATE THE POSTOPERATIVE EFFICACY OF 0.2% ROPIVACAINE ALONE IN COMBINED SPINAL EPIDURAL ANAESTHESIATimepoint: WITHIN 24 HOURS POST OPERATIVELY
- Secondary Outcome Measures
Name Time Method To compare the postoperative analgesic efficacy of 0.125% ropivacaine with 1 mcg fentanyl and 0.2 % ropivacaine alone in combined spinal anaesthesia.Timepoint: within 24 hours post operatively